Do-Do Chesteze
Last Updated on eMC 26-Feb-2013 View document | GlaxoSmithKline Consumer Healthcare Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 26-Feb-2013 and displayed until Current
Reasons for adding or updating:
- Change to section 1 - Name of the medicinal product
- Change to section 6.1 - List of excipients
Date of revision of text on the SPC: 15-Feb-2013
Legal Category:P
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Section 1: Removal of “Do-Do” as product name
Section 6.1: inclusion of components in “Colour brown” excipient
Updated on 20-Jun-2008 and displayed until 26-Feb-2013
Reasons for adding or updating:
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
Date of revision of text on the SPC: 11-Apr-2008
Legal Category:P
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Section 4.2: addition of “ Under 2 years : Do not use”
Section 4.4: addition of “ Do not take with other cough and cold medicine”
Section 10: date of revision changed from Feb 08 to 11 April 2008
Updated on 27-Feb-2008 and displayed until 20-Jun-2008
Reasons for adding or updating:
- New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
GlaxoSmithKline Consumer Healthcare
980 Great West Road, Brentford, Middlesex, TW8 9GS
0800 783 8881
0800 783 8881
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue